BDBM240987 US9409892, 82

SMILES CC(C)(CC(O)=O)NC(=O)c1nc(C#N)c2cc(Oc3ccccc3)ccc2c1O

InChI Key InChIKey=SHDGQLVOAGJTGP-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 240987   

TargetProlyl hydroxylase EGLN2(Human)
Fibrogen

US Patent
LigandPNGBDBM240987(US9409892, 82 | US20250099455, Compound Formula I)
Affinity DataIC50: 700nMAssay Description:Enzyme activity is determined by capturing 14CO2 using an assay described by Kivirikko and Myllyla (1982, Methods Enzymol. 82:245-304). Assay reactio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetProlyl hydroxylase EGLN2(Human)
Fibrogen

US Patent
LigandPNGBDBM240987(US9409892, 82 | US20250099455, Compound Formula I)
Affinity DataIC50: 910nMpH: 7.4Assay Description:Ketoglutaric acid α-[1-14C]-sodium salt, alpha-ketoglutaric acid sodium salt, and HPLC purified peptide may be obtained from commercial sources...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetProlyl hydroxylase EGLN2(Human)
Fibrogen

US Patent
LigandPNGBDBM240987(US9409892, 82 | US20250099455, Compound Formula I)
Affinity DataIC50: 910nMAssay Description:Enzyme activity is determined by capturing 14CO2 using an assay described by Kivirikko and Myllyla (1982, Methods Enzymol. 82:245-304). Assay reactio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEgl nine homolog 1(Human)
Fibrogen

US Patent
LigandPNGBDBM240987(US9409892, 82 | US20250099455, Compound Formula I)
Affinity DataIC50: 1.69E+4nMAssay Description:Enzyme activity is determined by capturing 14CO2 using an assay described by Kivirikko and Myllyla (1982, Methods Enzymol. 82:245-304). Assay reactio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEgl nine homolog 1(Human)
Fibrogen

US Patent
LigandPNGBDBM240987(US9409892, 82 | US20250099455, Compound Formula I)
Affinity DataIC50: 2.04E+4nMpH: 7.4Assay Description:Ketoglutaric acid α-[1-14C]-sodium salt, alpha-ketoglutaric acid sodium salt, and HPLC purified peptide may be obtained from commercial sources...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetEgl nine homolog 1(Human)
Fibrogen

US Patent
LigandPNGBDBM240987(US9409892, 82 | US20250099455, Compound Formula I)
Affinity DataIC50: 2.04E+4nMAssay Description:Enzyme activity is determined by capturing 14CO2 using an assay described by Kivirikko and Myllyla (1982, Methods Enzymol. 82:245-304). Assay reactio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent